Trafficking of Neuronal Two Pore Domain Potassium Channels

被引:27
|
作者
Mathie, Alistair [1 ]
Rees, Kathryn A.
El Hachmane, Mickael F.
Veale, Emma L.
机构
[1] Univ Kent, Medway Sch Pharm, Chatham ME4 4TB, Kent, England
关键词
Two pore domain potassium channel; TASK; TREK; p11; 14-3-3; endoplasmic reticulum; trafficking; neuronal membrane; K2P; ENDOPLASMIC-RETICULUM-LOCALIZATION; PROMOTES FUNCTIONAL EXPRESSION; BACKGROUND K-2P CHANNELS; K+ CHANNEL; SURFACE EXPRESSION; 14-3-3; PROTEINS; PLASMA-MEMBRANE; ION CHANNELS; BETA-SUBUNIT; CELL-PROLIFERATION;
D O I
10.2174/157015910792246146
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The activity of two pore domain potassium (K2P) channels regulates neuronal excitability and cell firing. Posttranslational regulation of K2P channel trafficking to the membrane controls the number of functional channels at the neuronal membrane affecting the functional properties of neurons. In this review, we describe the general features of K channel trafficking from the endoplasmic reticulum (ER) to the plasma membrane via the Golgi apparatus then focus on established regulatory mechanisms for K2P channel trafficking. We describe the regulation of trafficking of TASK channels from the ER or their retention within the ER and consider the competing hypotheses for the roles of the chaperone proteins 14-3-3, COP1 and p11 in these processes and where these proteins bind to TASK channels. We also describe the localisation of TREK channels to particular regions of the neuronal membrane and the involvement of the TREK channel binding partners AKAP150 and Mtap2 in this localisation. We describe the roles of other K2P channel binding partners including Arf6, EFA6 and SUMO for TWIK1 channels and Vpu for TASK1 channels. Finally, we consider the potential importance of K2P channel trafficking in a number of disease states such as neuropathic pain and cancer and the protection of neurons from ischemic damage. We suggest that a better understanding of the mechanisms and regulations that underpin the trafficking of K2P channels to the plasma membrane and to localised regions therein may considerably enhance the probability of future therapeutic advances in these areas.
引用
收藏
页码:276 / 286
页数:11
相关论文
共 50 条
  • [11] Two-pore domain potassium channels in sensory transduction
    Kim, Donghee
    NOCICEPTIVE MEMBRANE, 2006, 57 : 353 - 377
  • [12] Two-pore domain potassium channels in the adrenal cortex
    Bandulik, Sascha
    Tauber, Philipp
    Lalli, Enzo
    Barhanin, Jacques
    Warth, Richard
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2015, 467 (05): : 1027 - 1042
  • [13] Two-pore domain potassium channels in the adrenal cortex
    Sascha Bandulik
    Philipp Tauber
    Enzo Lalli
    Jacques Barhanin
    Richard Warth
    Pflügers Archiv - European Journal of Physiology, 2015, 467 : 1027 - 1042
  • [14] Research into the therapeutic roles of two-pore-domain potassium channels
    Es-Salah-Lamoureux, Zeineb
    Steele, David F.
    Fedida, David
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2010, 31 (12) : 587 - 595
  • [15] Expression of two pore domain potassium channels in airway epithelial cells
    Davis, KA
    Cowley, EA
    FASEB JOURNAL, 2004, 18 (05): : A1043 - A1043
  • [16] TRESK: The lone ranger of two-pore domain potassium channels
    Enyedi, Peter
    Braun, Gabriella
    Czirjak, Gabor
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2012, 353 (1-2) : 75 - 81
  • [17] Two-pore domain potassium channels Variation on a structural theme
    Braun, Andrew P.
    CHANNELS, 2012, 6 (03) : 139 - 140
  • [18] Molecular and functional properties of two-pore-domain potassium channels
    Lesage, F
    Lazdunski, M
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2000, 279 (05) : F793 - F801
  • [19] Neuronal trafficking of voltage-gated potassium channels
    Jensen, Camilla S.
    Rasmussen, Hanne B.
    Misonou, Hiroaki
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2011, 48 (04) : 288 - 297
  • [20] Molecular determinants of chemical modulation of two-pore domain potassium channels
    Sterbuleac, Daniel
    CHEMICAL BIOLOGY & DRUG DESIGN, 2019, 94 (03) : 1596 - 1614